Skip to content
Screener

D&A at other companies

Allient Inc. logo
Allient Inc.ALNT
$6.21M-1.1%
Nordson logo
NordsonNDSN
$36.32M-3.4%
Globus Medical logo
Globus MedicalGMED
$69.5M-1.6%
Belden logo
BeldenBDC
$32.46M+9.0%
Regal Rexnord logo
Regal RexnordRRX
$38.5M+8.5%
Crane Co. logo
Crane Co.CR
$27.4M+109%

Other financials

Income statement

See full
Revenue$265.8M+10.3%
Gross profit$120.9M+13.3%
Operating income$18.1M+21.1%
Net income$12.5M+179%
EPS (diluted)$0.30+150%

Balance sheet

See full
Cash & equivalents$718.7M+554%
Total debt$285.6M-44.5%
Total equity$1.6B+102%
Total assets$2.1B+41.6%

Cash flow

See full
Operating cash flow$64.9M+331%
CapEx$7.5M+120%
Free cash flow$57.5M+392%

Valuation

See full
Market cap$6.29B+54.6%
Enterprise value$5.86B+30.9%
P/E101.9×+35.5×
P/S6.1×+1.9×

Profitability

See full
Gross margin44.5%-0.2pp
Operating margin9%-2.2pp
Net margin6%-0.4pp
FCF margin11.1%-1.2pp

Returns & leverage

See full
Return on equity5.1%-3.1pp
Debt / equity0.2×-0.5×
Current ratio4.6×+2.0×

Where this comes from

Reported directly by Novanta in its filing.

Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.

The source filing: Novanta’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 5:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335404

FAQ

What is Novanta's D&A?
Novanta (NOVT) reported D&A of $14.65M in Q2 2026.
How has Novanta's D&A changed year-over-year?
Novanta's D&A decreased by 6.0% year-over-year, from $15.58M to $14.65M.
What is the long-term trend for Novanta's D&A?
Over 4 years (2021 to 2025), Novanta's D&A has grown at a 9.3% compound annual growth rate (CAGR), from $43.39M to $61.93M.
What does D&A mean?
Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Ask your AI about Novanta's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude